Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
0.6024
+0.0256 (4.44%)
At close: May 13, 2026, 4:00 PM EDT
0.6001
-0.0023 (-0.38%)
After-hours: May 13, 2026, 6:11 PM EDT

Lexaria Bioscience Market Cap

Lexaria Bioscience has a market cap or net worth of $14.93 million as of May 13, 2026. Its market cap has decreased by -30.22% in one year.

Market Cap
14.93M
Enterprise Value
9.76M
1-Year Change
-30.22%
Ranking
Category
Stock Price
$0.60

Market Cap Chart

Since February 12, 2007, Lexaria Bioscience's market cap has decreased from $19.40M to $14.93M, a decrease of -23.03%. That is a compound annual growth rate of -1.35%.

History

DateMarket Cap% Change
May 12, 202614.30M4.38%
Dec 31, 202513.70M-62.67%
Dec 31, 202436.70M186.72%
Dec 29, 202312.80M-12.33%
Dec 30, 202214.60M-36.80%
Dec 31, 202123.10M2.67%
Dec 31, 202022.50M-24.75%
Dec 31, 201929.90M-58.30%
Dec 31, 201871.70M-38.87%
Dec 29, 2017117.30M624.07%
Dec 30, 201616.20M131.43%
Dec 31, 20157.00M125.81%
Dec 31, 20143.10M342.86%
Dec 31, 2013700.00K-12.50%
Dec 31, 2012800.00K-77.78%
Dec 30, 20113.60M-7.69%
Dec 31, 20103.90M69.57%
Dec 31, 20092.30M130.00%
Dec 31, 20081.00M-94.71%
Dec 31, 200718.90M-2.58%
Feb 12, 200719.40M-
View and export this data all the way back to 2007. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
Cadrenal Therapeutics17.00M
IN8bio16.00M
Theriva Biologics15.65M
NewcelX15.27M
Genenta Science14.86M
Passage Bio14.11M
Vyome Holdings13.83M
BioLineRx13.50M
Market Cap Rankings